LINDSAY FALK: Open Payments
NPI 1750794640 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 11 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $634 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| Pulmonx Corporation | 2 | $287 |
| Boston Scientific Corporation | 2 | $168 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| BeOne Medicines USA, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| PharmaEssentia USA Corporation | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| ABBVIE INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CHARTIS CATHETER, WATCHMAN FLX, INGREZZA, BRUKINSA, DUPIXENT, BESREMI, AUSTEDO XR, QULIPTA.
Industry payments across FL — which companies pay providers there.
